We understand that Allergic Rhinitis(AR) can impact on general health,
well-being and quality of life.
Allergic Rhinitis is estimated to be present in 10 to 30% of adults and up to 40% of children.1 The
overall treatment plan for each individual will vary with history and symptom complex.
Overall treatment will depend on a combination of :
Avoidance measures and Environmental controls
2. Oral medications
3. Topical Medications
4. Steroid therapy
5. Immunotherapy (allergy shots)
Avoidance measures and environmental control measures can provide an important treatment for allergies.
Dust mites, cat and dog dander, mold spores, and pollen are common causes of inhalant allergies.
Environmental controls most commonly recommended:
* Mattress, Pillow, Box Spring, and Comforter Encasings
* Washing sheets, blankets, pads, etc. in hot water
* Vent/Register filters
* True HEPA air cleaners, Air Cleaner
* 3% Tannic acid solutions
* Regular pet bathing
* Dust mite treatment for carpets
* Controlling humidity
* Air filtration: whole house and filters
* Mold/Mildew prevention
* “Dustless” Vacuum cleaners
* Filtration masks for outdoor activities
* Limit or Do not open windows during active allergy seasons
* Clothing worn outdoors will have allergens on them. Be sure to change and wash these
Allergic Avoidance may also involve food and herbal supplements. Some times certain foods can sensitize
(make you more allergic) to your known allergies. When this happens, you can trigger your allergy with a lower
threshold of exposure.
Allergy Medications include a variety of OTC (over-the-counter) medications, prescription
antihistamines, leukotriene inhibitors, topical nasal steroids, oral steroids and immunotherapy (allergy
Often combination therapy may be used to best control your symptoms.
1.Dykewicz MS, Fineman S, Skoner DP, et. al. Diagnosis and Management of
Rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology.
American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998;81(5 pt2);478-518